We provide full-lifecycle GMP-compliant biopharmaceutical technology transfer and scale-up services tailored for novel drugs, biosimilars, mRNA vaccines, cell therapies and recombinant protein products. Fully aligned with FDA cGMP, EU GMP and global biomanufacturing regulatory frameworks, our standardized technology migration system bridges laboratory-scale R&D and commercial industrial production. Adopting quality-by-design and process reproducibility principles, we deliver audit-ready technical conversion solutions that eliminate process deviation, data discontinuity and scale-up failure risks for seamless clinical translation and mass production iteration.
Our core services cover systematic process verification, parameter optimization and stable scale-up transformation across upstream, midstream and downstream bioprocessing workflows. We conduct in-depth technical sorting of original laboratory formulas, culture parameters, purification logic and sterile operation specifications, calibrating scalable process parameters suitable for industrial equipment and GMP workshop environments. Professional hydrodynamic simulation, cell culture amplification optimization and impurity removal process upgrading resolve common scale-up pain points including low yield, increased aggregation and unstable batch quality. All optimized processes maintain complete consistency with original drug efficacy and quality standards to ensure regulatory compliance and product homogeneity.
Covering comprehensive turnkey technical services, our scope includes R&D-to-production process docking, technology document sorting and upgrading, GMP-compliant process validation, equipment parameter matching, personnel operation training, pilot-scale trial production verification and formal scale-up batch confirmation. We establish standardized technology transfer dossiers covering full-process SOPs, parameter specifications, quality control standards and deviation handling mechanisms. Full-process data traceability and batch repeatability verification fully meet global drug registration, regulatory inspection and commercial batch release requirements, supporting stable and sustainable industrial production.
Empowered by rich cross-stage bioprocess conversion experience, our technology transfer and scale-up services effectively shorten product industrialization cycles and reduce trial-and-error costs. Systematic process standardization eliminates technical barriers between lab research and factory production, significantly improving production yield and batch consistency. Flexible scale-up schemes support phased capacity upgrading, multi-batch stable replication and subsequent process continuous optimization. We help biopharmaceutical enterprises complete efficient, compliant and low-risk technical transformation, accelerating new drug listing, market expansion and long-term industrial value realization.
